Stifel Downgrades Lowes to Sell • Rezolute Rises on upLIFT Data • Candel Falls 35% on BLA Delay | Business and Finance News

Podcast: Business News Today | 2 Min News | The Daily News Now! · The Daily News Now!

Opublikowano: 2026-11-13

Stifel downgraded Lowes to Sell and kept a cautious view on Home Depot on valuation and demand concerns, Rezolute shares rose after positive Phase 3 upLIFT trial results, and Candel Therapeutics shares fell 35% after delaying its BLA for a prostate cancer therapy. ⸻ Stories & Sources Stifel downgrades Lowe’s to Sell, stays cautious on Home Depot ahead of earnings https://findsource.ai/s/vnzsy Rezolute stock rises on positive Phase 3 upLIFT trial results https://findsource.ai/s/13p2d Candel Therapeutics stock plummets 35% on prostate cancer BLA delay http...